David J. Lederer, MD
Associate Professor of Medicine and Epidemiology; Director, Pulmonary & Intensive Care Translational Outcomes Research (PICTOR) Group
Columbia University Medical Center and Columbia University
Dr. Lederer is an Associate Professor and pulmonologist at Columbia University Medical Center in New York, where he cares for adults with interstitial lung disease and idiopathic pulmonary fibrosis. Dr. Lederer is an NIH-funded clinical and epidemiological investigator who discovered a novel method of measuring early lung inflammation and extracellular matrix remodeling detected years before the onset of pulmonary fibrosis using quantitative CT imaging in the MESA Lung Fibrosis Study, permitting the study of the earliest causes of pulmonary fibrosis. He also leads the NHLBI-funded Lung Transplant Body Composition study which has identified obesity, sarcopenia, and frailty as clinically relevant body composition phenotypes in adults with advanced lung disease. He also investigates the link between sleep apnea and early lung injury. His work has uncovered disparities in accessing subspecialty care and lung transplantation services in the United States, focusing on delays in referral, race, ethnicity, and short stature.
Dr. Lederer is a Senior Medical Advisor for the Pulmonary Fibrosis Foundation and sits on the Executive Medical Team at the PFF. He is a Deputy Editor of the Annals of the American Thoracic Society, a Statistical Editor for Thorax, and sits on the Editorial Board of the American Journal of Respiratory and Critical Care Medicine. He is a standing member of the IRAP Study Section at the Center for Scientific Review at the NIH and the NHLBI K23 Study Section. He sits on the Technical Advisory Committee for the Scientific Registry of Transplant Recipients. Dr. Lederer blogs at PFDoc.org for patients with pulmonary fibrosis.